Document Detail

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan.
MedLine Citation:
PMID:  23387475     Owner:  NLM     Status:  Publisher    
Objective To examine the efficacy, acceptability and feasibility of early medical abortion, with the option of home administration of misoprostol, in Uzbekistan. Methods A total of 450 women were enrolled at national, municipal and private facilities in Tashkent, Uzbekistan. Women who presented for termination of pregnancy with gestations up to 63 days were recruited to participate in the study. All eligible pregnant women who consented to participate swallowed a 200 mg mifepristone pill in the clinic and were given the option of taking 400 μg misoprostol sublingually either at the clinic or at home 24-48 hours after mifepristone administration. Abortion status was determined two weeks later. Results Almost all women (99.5%) chose home administration of misoprostol. The sublingual route of misoprostol administration was acceptable or very acceptable to 89% of participants. Ninety-five percent of women had complete abortions after mifepristone and misoprostol. Almost all participants preferred a medical abortion to surgery for a future procedure (95%). Conclusions Mifepristone medical abortion with home administration of misoprostol is an acceptable and feasible option for women in Uzbekistan. The method worked well at all three facility types.
Sheila Raghavan; Tamar Tsereteli; Asamidin Kamilov; Dilfuza Kurbanbekova; Dilmurod Yusupov; Feruza Kasimova; Dilbar Jymagylova; Beverly Winikoff
Related Documents :
25002305 - Evaluating the use of mobile phone technology to enhance cardiovascular disease screeni...
24100805 - Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?
23975265 - Incorporation of assessments of risk of bias of primary studies in systematic reviews o...
15794495 - A longitudinal study of industrial and clerical workers: predictors of upper extremity ...
19534585 - Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced ...
20698925 - Orthostatic hypotension and long-term incidence of atrial fibrillation: the malmö prev...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-7
Journal Detail:
Title:  The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception     Volume:  -     ISSN:  1473-0782     ISO Abbreviation:  Eur J Contracept Reprod Health Care     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9712127     Medline TA:  Eur J Contracept Reprod Health Care     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
* Gynuity Health Projects , New York , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Joint (Mis-)Representations: A Reply to Welsh et al. (2013).
Next Document:  Delta-like 1 Homologue (DLK1) is a Hypothalamus-Enriched Protein that is Present in Orexin-, but not...